J R Fozard1, J P Hannon. Show Affiliations » 1. Novartis Pharma AG, WSJ-386.508, Basel, CH-4002, Switzerland.
Abstract
Entities: Disease
Mesh: See more » AnimalsAnti-Asthmatic Agents/pharmacologyAnti-Asthmatic Agents/therapeutic useAsthma/drug therapyAsthma/physiopathologyBronchodilator Agents/pharmacologyBronchodilator Agents/therapeutic useHumansLigandsLung Diseases, Obstructive/drug therapyLung Diseases, Obstructive/physiopathologyReceptors, Purinergic P1/drug effectsReceptors, Purinergic P1/metabolismTheophylline/pharmacologyTheophylline/therapeutic useXanthines/pharmacologyXanthines/therapeutic use
Substances: See more » Anti-Asthmatic AgentsBronchodilator AgentsLigandsReceptors, Purinergic P1XanthinesTheophyllineenprofylline
Year: 1999 PMID: 10373392 DOI: 10.1006/pupt.1999.0191
Source DB: PubMed Journal: Pulm Pharmacol Ther ISSN: 1094-5539 Impact factor: 3.410